Inovio Pharmaceuticals Inc (INO)

May 30, 2025

Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch

May 30, 2025

May 27, 2025

Inovio’s SWOT analysis: dna immunotherapy firm faces crucial year for stock - Investing.com Australia

May 27, 2025

May 23, 2025

Inovio shareholders approve board nominees and proposals By Investing.com - Investing.com Canada

May 23, 2025

May 22, 2025

Inovio shareholders approve board nominees and proposals - Investing.com Australia

May 22, 2025

May 22, 2025

Inovio Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks

May 22, 2025

May 19, 2025

INOVIO Reports Q1 2025 Results and Key Developments in DNA Medicines - MyChesCo

May 19, 2025

May 17, 2025

Q2 EPS Estimate for Inovio Pharmaceuticals Cut by Analyst - Defense World

May 17, 2025

May 16, 2025

Inovio Pharmaceuticals (INO) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 16, 2025

May 15, 2025

Inovio Pharmaceuticals’ Earnings Call: Progress Amid Challenges - TipRanks

May 15, 2025

May 15, 2025

Inovio Pharmaceuticals (INO) Sees Price Target Adjustment by Opp - GuruFocus

May 15, 2025

May 15, 2025

Inovio outlines BLA submission timeline for INO-3107 and reports $68.4M cash position while advancing DNA medicine pipeline - MSN

May 15, 2025

May 14, 2025

Inovio Pharmaceuticals (INO) Maintains Sector Perform Rating by RBC Capital | INO Stock News - GuruFocus

May 14, 2025

May 14, 2025

Oppenheimer cuts Inovio stock price target to $13 By Investing.com - Investing.com Nigeria

May 14, 2025

May 14, 2025

INO Reports Strong Q1 Revenue, Progress on INO-3107 Submission | - GuruFocus

May 14, 2025

May 14, 2025

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q1 2025 Earnings Call Transcript - Insider Monkey

May 14, 2025

May 14, 2025

Inovio (INO) Receives Revised Price Target from Oppenheimer | IN - GuruFocus

May 14, 2025

May 14, 2025

Inovio Pharmaceuticals: Hold Rating Due to Financial Losses and Uncertain Development Timeline - TipRanks

May 14, 2025

May 14, 2025

Inovio stock holds $12 target, JMP affirms Market Outperform By Investing.com - Investing.com Canada

May 14, 2025

May 14, 2025

Inovio stock holds $12 target, JMP affirms Market Outperform - Investing.com Australia

May 14, 2025

May 14, 2025

Inovio Pharmaceuticals Inc (INO) Q1 2025 Earnings Call Highlights: Strategic Cost Management ... - Yahoo Finance

May 14, 2025

May 14, 2025

Inovio Pharmaceuticals Q1 2025 Earnings Call Transcript - MarketBeat

May 14, 2025

May 13, 2025

Inovio Pharmaceuticals (INO) Advances BLA Submission for INO-310 - GuruFocus

May 13, 2025

May 13, 2025

INOVIO Reports First Quarter 2025 Financial Results and Recent B - GuruFocus

May 13, 2025

May 13, 2025

Earnings call transcript: Inovio’s Q1 2025 sees narrowed losses, stock rises - Investing.com India

May 13, 2025

May 13, 2025

Inovio: Q1 Earnings Snapshot - San Francisco Chronicle

May 13, 2025

May 13, 2025

Inovio Pharmaceuticals Inc (INO) Q1 2025 Earnings: EPS of -$0.51 - GuruFocus

May 13, 2025

May 13, 2025

Inovio Pharmaceuticals Q1 Operating Expenses USD 25.1 Million - marketscreener.com

May 13, 2025

May 13, 2025

INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights - PR Newswire

May 13, 2025

May 13, 2025

Inovio Pharmaceuticals Q1 25 Earnings Conference Call At 4:30 PM ET - Nasdaq

May 13, 2025

May 13, 2025

Options Volatility and Implied Earnings Moves Today, May 13, 2025 - The Globe and Mail

May 13, 2025

May 13, 2025

Inovio Pharmaceuticals (NASDAQ:INO) Lowered to “Sell” Rating by StockNews.com - Defense World

May 13, 2025

May 13, 2025

INOVIO Reports First Quarter 2025 Financial Results and Recent Business Highlights | INO Stock News - GuruFocus

May 13, 2025

May 11, 2025

Inovio Pharmaceuticals (INO) Expected to Announce Quarterly Earnings on Tuesday - Defense World

May 11, 2025

May 08, 2025

Inovio at The Citizens JMP Life Sciences Conference: DNA Platform Progress - Investing.com Australia

May 08, 2025

May 05, 2025

Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Shares Sold by Renaissance Technologies LLC - Defense World

May 05, 2025

May 05, 2025

Inovio Pharmaceuticals (NASDAQ:INO) Cut to Sell at StockNews.com - Defense World

May 05, 2025

May 03, 2025

INOVIO to Report First Quarter 2025 Financial Results on May 13, 2025 - Kilgore News Herald

May 03, 2025

May 02, 2025

Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch

May 02, 2025

May 02, 2025

INOVIO to Announce Q1 2025 Results and Host Live Webcast on May 13 - MyChesCo

May 02, 2025

May 01, 2025

Geode Capital Management LLC Boosts Stake in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Defense World

May 01, 2025

May 01, 2025

INOVIO to Present at Upcoming Scientific and Investor Conferences - The Bradford Era

May 01, 2025

Apr 30, 2025

INOVIO to Present at Upcoming Scientific and Investor Conferences | INO Stock News - GuruFocus

Apr 30, 2025

Apr 30, 2025

XTX Topco Ltd Acquires New Position in Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Defense World

Apr 30, 2025